At Bumrungrad International Hospital, we are proud to lead this new era, helping patients achieve lasting weight loss and metabolic health with advanced, personalized care
Tirzepatide activates both GLP-1 and GIP receptors, which can enhance insulin sensitivity and fat metabolism more effectively than semaglutide for some people
During this period, interventions such as stimulus control, self-monitoring, and expectation management may be particularly effective
MHRA reminds healthcare professionals to advise patients of the side effects of GLP-1 agonists and to report misuse
When you inject on a consistent day and time each week, your body maintains stable medication levels, which leads to more predictable appetite suppression and better blood sugar control